Cell type name | GTRD ID | Experiments count | ASBs at 25% FDR | ASBs at 10% FDR | ASBs at 5% FDR |
|---|---|---|---|---|---|
| MCF10A (breast epithelial cells) | 583 | 111 | 99766 | 5355 | 1729 |
| 22RV1 (prostate carcinoma) | 7 | 57 | 62962 | 34706 | 25131 |
| GM12878 (female B-cells lymphoblastoid cell line) | 356 | 287 | 56145 | 36581 | 28386 |
| K562 (myelogenous leukemia) | 514 | 819 | 39682 | 31310 | 27468 |
| BEAS-2B (bronchial epithelium) | 87 | 33 | 33535 | 14194 | 9252 |
| MCF7 (Invasive ductal breast carcinoma) | 113 | 860 | 26525 | 12866 | 9596 |
| HT1080 (fibrosarcoma) | 1008 | 21 | 20954 | 3325 | 1434 |
| breast tumor | 1123 | 26 | 19122 | 11720 | 8697 |
| HEK293 (embryonic kidney) | 421 | 453 | 18844 | 14751 | 12724 |
| HepG2 (hepatoblastoma) | 430 | 460 | 17611 | 11682 | 9580 |
| CTV-1 (Adult T acute lymphoblastic leukemia) | 4712 | 31 | 16622 | 9442 | 6913 |
| CD14+ monocytes | 157 | 10 | 13492 | 9118 | 7276 |
| foreskin keratinocyte | 1185 | 3 | 12806 | 9126 | 7381 |
| primary B-CLL cells | 2259 | 3 | 12298 | 8066 | 6188 |
| HUVEC-C (HUVEC, umbilical vein endothelial cells) | 472 | 109 | 12176 | 8183 | 6353 |
| LNCaP (prostate carcinoma) | 70 | 402 | 11774 | 7215 | 5733 |
| MDM(monocyte derived macrophages) | 466 | 50 | 11738 | 7772 | 5895 |
| neural cell | 1180 | 10 | 10942 | 4865 | 3013 |
| iPS-derived dermal fibroblasts | 4297 | 6 | 10877 | 2295 | 1059 |
| MS-1 (Small cell lung carcinoma) | 2656 | 2 | 10837 | 5302 | 3562 |
| HCT-116 (colon carcinoma) | 417 | 207 | 10081 | 4105 | 2708 |
| A549 (lung carcinoma) | 38 | 299 | 9221 | 5834 | 4516 |
| GM19238 (female B-cells lymphoblastoid cell lines) | 367 | 3 | 8815 | 4544 | 3211 |
| GM19239 (male B-cells lymphoblastoid cell line) | 368 | 3 | 8781 | 4570 | 3117 |
| GM02610 (Lymphoblastoid Cell Lines) | 2654 | 2 | 8693 | 4652 | 3147 |